ReviewBriefings in bioinformatics2025
Minimal cut sets in metabolic networks: from conceptual foundations to applications in metabolic engineering and biomedicine.
Review in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- gMISpy: integration of complex regulatory networks and genome scale metabolic models.Bioinformatics (Oxford, England) · 2026Article
- Model-guided chemical environment and metabolic network design to couple pathways with cell fitness.Metabolic engineering communications · 2025Article
- Balancing Cell Growth and Product Synthesis for Efficient Microbial Cell Factories.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Minimal cut sets (MCSs) have emerged as an important branch of constraint-based metabolic modeling, offering a versatile framework for analyzing and engineering metabolic networks. Over the past two decades, MCSs have evolved from a theoretical concept into a powerful tool for identifying tailored metabolic intervention strategies and studying robustness and failure modes of metabolic networks. Successful (experimental) applications range from designing highly efficient microbial cell factories to targeting cancer cell metabolism. This review highlights key conceptual and algorithmic advancements that have transformed MCSs into a flexible methodology applicable to metabolic models of any size. It also provides a comprehensive overview of their applications and concludes with a perspective on future research directions. The review aims to equip both newcomers and experts with the knowledge needed to effectively leverage MCSs for metabolic network analysis and design, therapeutic targeting, and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.